MADISON RIVER OAKS MEDICAL CENTER
1. Target Overview & Investment Thesis
MADISON RIVER OAKS MEDICAL CENTER is a 67-bed rural/critical access in MADISON, MS with $32.9M in net patient revenue and a -1.2% operating margin. The hospital serves a payer mix of 39.7% Medicare, 6.6% Medicaid, and 53.7% commercial.
Thesis: Turnaround. Our ML models identify $2.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.2% to 6.1% (+736bps).
| Net Revenue HCRIS | $32.9M |
| Current EBITDA COMPUTED | $-407K |
| Operating Margin COMPUTED | -1.2% |
| Occupancy HCRIS | 19.1% |
| Revenue / Bed COMPUTED | $490K |
| Net-to-Gross HCRIS | 9.7% |
| Distress Probability ML | 55.1% |
2. Market Context & Competitive Position
MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of -1.2% places it above the state median. Among 39 size-comparable peers (34-134 beds), the median margin is -8.5%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (34-134), prioritizing same-state peers. 39 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MADISON RIVER OAKS MEDICAL CEN (Target) | MS | 67 | $32.9M | -1.2% |
| MERIT HEALTH WESLEY | MS | 121 | $140.9M | 1.3% |
| SOUTHWEST MS REGIONAL MED CENT | MS | 97 | $123.1M | -16.0% |
| BAPTIST MEM HOSPITAL UNION COU | MS | 83 | $117.9M | 3.7% |
| DELTA HEALTH-THE MEDICAL CENTE | MS | 101 | $112.1M | -26.9% |
| SINGING RIVER GULFPORT | MS | 100 | $92.5M | -12.7% |
| BILOXI REGIONAL MEDICAL CENTER | MS | 121 | $78.3M | -3.6% |
| METHODIST H/C OLIVE BRANCH HOS | MS | 65 | $75.4M | -25.6% |
| UMMC-GRENADA | MS | 49 | $63.7M | 7.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $690K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $657K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $651K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $400K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $21K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-407K |
| + RCM Uplift | +$2.4M |
| Pro Forma EBITDA | $2.0M |
| Current Margin | -1.2% |
| Pro Forma Margin | 6.1% |
| WC Released (1x) | $1.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-627K | $21.5M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-627K | $23.4M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-564K | $31.2M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-564K | $33.9M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-689K | $9.6M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-689K | $10.3M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 19.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 55.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 39 hospitals with 34-134 beds
- Same-state prioritization (n=40)
- Comp margins: P25=-22.5% / P50=-8.5% / P75=3.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.